393 related articles for article (PubMed ID: 25917093)
1. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
Nozal P; Bernabéu-Herrero ME; Uzonyi B; Szilágyi Á; Hyvärinen S; Prohászka Z; Jokiranta TS; Sánchez-Corral P; López-Trascasa M; Józsi M
Mol Immunol; 2016 Feb; 70():47-55. PubMed ID: 26703217
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
4. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
5. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
[TBL] [Abstract][Full Text] [Related]
6. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
7. Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome.
Blanc C; Roumenina LT; Ashraf Y; Hyvärinen S; Sethi SK; Ranchin B; Niaudet P; Loirat C; Gulati A; Bagga A; Fridman WH; Sautès-Fridman C; Jokiranta TS; Frémeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2012 Oct; 189(7):3528-37. PubMed ID: 22922817
[TBL] [Abstract][Full Text] [Related]
8. Factor H Autoantibodies and Complement-Mediated Diseases.
Zhang Y; Ghiringhelli Borsa N; Shao D; Dopler A; Jones MB; Meyer NC; Pitcher GR; Taylor AO; Nester CM; Schmidt CQ; Smith RJH
Front Immunol; 2020; 11():607211. PubMed ID: 33384694
[TBL] [Abstract][Full Text] [Related]
9. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
[TBL] [Abstract][Full Text] [Related]
10. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
[TBL] [Abstract][Full Text] [Related]
11. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
Foltyn Zadura A; Zipfel PF; Bokarewa MI; Sturfelt G; Jönsen A; Nilsson SC; Hillarp A; Saxne T; Trouw LA; Blom AM
Arthritis Res Ther; 2012 Aug; 14(4):R185. PubMed ID: 22894814
[TBL] [Abstract][Full Text] [Related]
12. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
Dragon-Durey MA; Blanc C; Marliot F; Loirat C; Blouin J; Sautes-Fridman C; Fridman WH; Frémeaux-Bacchi V
J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder.
Uzonyi B; Szabó Z; Trojnár E; Hyvärinen S; Uray K; Nielsen HH; Erdei A; Jokiranta TS; Prohászka Z; Illes Z; Józsi M
Front Immunol; 2021; 12():660382. PubMed ID: 33986750
[TBL] [Abstract][Full Text] [Related]
14. Anti-complement-factor H-associated glomerulopathies.
Durey MA; Sinha A; Togarsimalemath SK; Bagga A
Nat Rev Nephrol; 2016 Sep; 12(9):563-78. PubMed ID: 27452363
[TBL] [Abstract][Full Text] [Related]
15. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
[TBL] [Abstract][Full Text] [Related]
16. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
Front Immunol; 2018; 9():848. PubMed ID: 29740447
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
[TBL] [Abstract][Full Text] [Related]
18. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
[TBL] [Abstract][Full Text] [Related]
19. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
Cugno M; Berra S; Depetri F; Tedeschi S; Griffini S; Grovetti E; Caccia S; Cresseri D; Messa P; Testa S; Giglio F; Peyvandi F; Ardissino G
J Am Soc Nephrol; 2021 May; 32(5):1227-1235. PubMed ID: 33712527
[TBL] [Abstract][Full Text] [Related]
20. The autoimmune disease DEAP-hemolytic uremic syndrome.
Skerka C; Zipfel PF; Müller D; Micklisch S; Riedl M; Zimmerhackl LB; Hofer J
Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
